| |
Welcome |  | Immunomic Therapeutics' website is your resource for news & updates about the Company as well a wealth of technical and informational content.
For general information about ITI, its management team and our vision, we invite you to explore the About Us section. If you are interested in learning a little basic immunology and how vaccines can be used to treat allergies, visit our Immunology 101 section. We are also planning on adding a multi-media section to further your understanding of LAMP-vax Technology and our developing vaccine product line. | | About us | |
Immunomic Therapeutics, Inc. (ITI) is a clinical stage biotechnology company with exceptional science for application to vaccines and vaccine immunotherapies. The promise of our LAMP-vax Technology is to increase the effectiveness of the immune response to DNA vaccines while simplifying overall vaccine design and delivery. The LAMP-vax Technology is ideally suited for application to allergy immunotherapy and the company is planning to initiate a clinical study for its lead product, JRC-LAMP-vax in 2011. There is both industry and clinical validation for this breakthrough science. | |
Latest news | | November 1st, 2012
Immunomic Therapeutics Completes Bio-Distribution Study It is available to read online.
Sept 15th, 2011
Immunomics launches Series A Funding Initive.
More information is available in our News Section. August 31st, 2011
Immunomic Therapeutics Begins cGMP Manufacture of Clinical Doses of JRC-LAMP-vax More information is available in our News Section.
| |
